<DOC>
	<DOC>NCT00945321</DOC>
	<brief_summary>This study will assess the bioequivalence of single oral doses of aprepitant (MK0869) to a single intravenous infusion of fosaprepitant (MK0517) and also determine the effect of food on the bioavailability of oral aprepitant.</brief_summary>
	<brief_title>A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165)</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<criteria>Subject is in good health Subject is a nonsmoker Subject is willing to comply with the study restrictions Subject has a history of any illness that might confound the results of the study or might make participation in the study unsafe Subject has a history of stroke, seizures, or major neurological disorder Subject has a history of cancer Subject consumes more than two alcoholic drinks per day Subject consumes more than three caffeinated beverages daily</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>